ZyVersa Therapeutics Stock Forecast - Period Momentum Indicator
| ZVSA Stock | 1.07 0.04 3.60% |
ZyVersa Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ZyVersa Therapeutics stock prices and determine the direction of ZyVersa Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ZyVersa Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
ZyVersa |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.05) | (0.04) |
| Check ZyVersa Therapeutics Volatility | Backtest ZyVersa Therapeutics | Information Ratio |
ZyVersa Therapeutics Trading Date Momentum
| On November 28 2024 ZyVersa Therapeutics was traded for 1.07 at the closing time. The top price for the day was 1.13 and the lowest listed price was 1.05 . There was no trading activity during the period 0.0. Lack of trading volume on November 28, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 4.67% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare ZyVersa Therapeutics to competition |
Other Forecasting Options for ZyVersa Therapeutics
For every potential investor in ZyVersa, whether a beginner or expert, ZyVersa Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ZyVersa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ZyVersa. Basic forecasting techniques help filter out the noise by identifying ZyVersa Therapeutics' price trends.ZyVersa Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ZyVersa Therapeutics stock to make a market-neutral strategy. Peer analysis of ZyVersa Therapeutics could also be used in its relative valuation, which is a method of valuing ZyVersa Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ZyVersa Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ZyVersa Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ZyVersa Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ZyVersa Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how ZyVersa Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ZyVersa Therapeutics shares will generate the highest return on investment. By undertsting and applying ZyVersa Therapeutics stock market strength indicators, traders can identify ZyVersa Therapeutics entry and exit signals to maximize returns.
ZyVersa Therapeutics Risk Indicators
The analysis of ZyVersa Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ZyVersa Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zyversa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.1 | |||
| Standard Deviation | 8.19 | |||
| Variance | 67.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ZyVersa Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ZyVersa Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zyversa Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zyversa Therapeutics Stock:Check out Historical Fundamental Analysis of ZyVersa Therapeutics to cross-verify your projections. For information on how to trade ZyVersa Stock refer to our How to Trade ZyVersa Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ZyVersa Therapeutics. If investors know ZyVersa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ZyVersa Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 491.97 | Return On Assets (0.25) | Return On Equity (1.52) |
The market value of ZyVersa Therapeutics is measured differently than its book value, which is the value of ZyVersa that is recorded on the company's balance sheet. Investors also form their own opinion of ZyVersa Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ZyVersa Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ZyVersa Therapeutics' market value can be influenced by many factors that don't directly affect ZyVersa Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ZyVersa Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ZyVersa Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ZyVersa Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.